Last Updated : November 27, 2013
Details
FilesGeneric Name:
Mirabegron
Project Status:
Complete
Therapeutic Area:
Overactive bladder
Manufacturer:
Astellas Pharma Canada Inc.
Call for patient/clinician input open:
Brand Name:
Myrbetriq
Project Line:
Reimbursement Review
Project Number:
SR0363-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Bladder, overactive
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : November 27, 2013